nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Note of Thanks
|
|
|
2014 |
36 |
12 |
p. A8-A10 |
artikel |
2 |
Antidepressant Agents in Short Bowel Syndrome
|
Faye, Elodie |
|
2014 |
36 |
12 |
p. 2029-2033.e3 |
artikel |
3 |
A Review of Sucroferric Oxyhydroxide for the Treatment of Hyperphosphatemia in Patients Receiving Dialysis
|
Bousher, Ava |
|
2014 |
36 |
12 |
p. 2082-2093 |
artikel |
4 |
Author index
|
|
|
2014 |
36 |
12 |
p. 2122-2128 |
artikel |
5 |
Clinical Outcomes and Incremental Costs From a Medication Adherence Pilot Intervention Targeting Low-Income Patients With Diabetes at Risk of Cost-Related Medication Nonadherence
|
Ryan, John G. |
|
2014 |
36 |
12 |
p. 1991-2002 |
artikel |
6 |
Comparison of the Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke and Systemic Embolism in Atrial Fibrillation in a UK Setting
|
Zheng, Ying |
|
2014 |
36 |
12 |
p. 2015-2028.e2 |
artikel |
7 |
Complementary and Alternative Medical Therapies in Multiple Sclerosis–The American Academy of Neurology Guidelines: A Commentary
|
Yadav, Vijayshree |
|
2014 |
36 |
12 |
p. 1972-1978 |
artikel |
8 |
Computed Tomography Image Analysis Before and After Treatment of Anti-Neutrophil Cytoplasmic Antibody−Associated Pulmonary Interstitial Fibrosis in 8 Patients
|
Yu, Ai-Ping |
|
2014 |
36 |
12 |
p. 2064-2071 |
artikel |
9 |
Critical Appraisal of the SHARP Trial: The Results May Be Dull
|
Harbin, Megan |
|
2014 |
36 |
12 |
p. 2112-2117 |
artikel |
10 |
Current and Emerging Therapies for Multiple Sclerosis
|
Patwa, Huned S. |
|
2014 |
36 |
12 |
p. 1936-1937 |
artikel |
11 |
Dapoxetine for Premature Ejaculation: An Updated Meta-Analysis of Randomized Controlled Trials
|
Li, Jinhong |
|
2014 |
36 |
12 |
p. 2003-2014 |
artikel |
12 |
Do Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Cause Heart Failure?
|
Clifton, Peter |
|
2014 |
36 |
12 |
p. 2072-2079 |
artikel |
13 |
Effect of Low Birth Weight on Women’s Health
|
Alexander, Barbara T. |
|
2014 |
36 |
12 |
p. 1913-1923 |
artikel |
14 |
Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
|
Kita, Mariko |
|
2014 |
36 |
12 |
p. 1958-1971 |
artikel |
15 |
Estrogen in Cardiovascular Disease during Systemic Lupus Erythematosus
|
Gilbert, Emily L. |
|
2014 |
36 |
12 |
p. 1901-1912 |
artikel |
16 |
Gender Medicine: “In a Perfect World …”
|
Reckelhoff, Jane F. |
|
2014 |
36 |
12 |
p. 1870-1872 |
artikel |
17 |
Management of Newer Medications for Attention-Deficit/Hyperactivity Disorder in Commercial Health Plans
|
Hodgkin, Dominic |
|
2014 |
36 |
12 |
p. 2034-2046 |
artikel |
18 |
Meta-Analysis to Assess the Efficacy and Toxicity of Docetaxel-Based Doublet Compared with Docetaxel Alone for Patients with Advanced NSCLC who Failed First-Line Treatment
|
Jin, Ying |
|
2014 |
36 |
12 |
p. 1980-1990 |
artikel |
19 |
New Approaches for Managing Preeclampsia: Clues From Clinical and Basic Research
|
George, Eric M. |
|
2014 |
36 |
12 |
p. 1873-1881 |
artikel |
20 |
Pharmacokinetics and Pharmacodynamics of Setrobuvir, an Orally Administered Hepatitis C Virus Non-Nucleoside Analogue Inhibitor
|
Mallalieu, Navita L. |
|
2014 |
36 |
12 |
p. 2047-2063.e3 |
artikel |
21 |
Risk of Vascular Disease in Premenopausal Women With Diabetes Mellitus
|
García, Néstor H. |
|
2014 |
36 |
12 |
p. 1924-1934 |
artikel |
22 |
Role of Clinical Pharmacology in the Development of Antiplatelet Drugs
|
Patrono, Carlo |
|
2014 |
36 |
12 |
p. 2096-2111 |
artikel |
23 |
Selective COX-2 Inhibitors Suppress Prostacyclin
|
Skarke, Carsten |
|
2014 |
36 |
12 |
p. 2120-2121 |
artikel |
24 |
Sex Differences in T Cells in Hypertension
|
Tipton, Ashlee J. |
|
2014 |
36 |
12 |
p. 1882-1900 |
artikel |
25 |
Sex Versus Gender: A Touchy Subject for Multiple Sclerosis
|
Shader, Richard I. |
|
2014 |
36 |
12 |
p. 1865-1867 |
artikel |
26 |
Subject Index
|
|
|
2014 |
36 |
12 |
p. 2129-2140 |
artikel |
27 |
The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis
|
Hupperts, Raymond |
|
2014 |
36 |
12 |
p. 1946-1957 |
artikel |
28 |
Update on Disease-Modifying Treatments for Multiple Sclerosis
|
Carrithers, Michael D. |
|
2014 |
36 |
12 |
p. 1938-1945 |
artikel |